Epilepsia partialis continua as an early sign of anti-myelin oligodendrocyte glycoprotein antibody-positive encephalitis

5Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies have been associated with steroid-responsive cortical encephalitis and comorbid generalized epilepsy. A 44-year-old woman developed repeated epilepsia partialis continua (EPC) without generalized seizures and was anti-MOG antibody-positive. Radiological abnormalities were detected in the bilateral medial frontoparietal cortices, but there were no cerebrospinal fluid abnormalities. She achieved remission with anti-epileptic drugs alone. However, encephalitis recurred four months later when pleocytosis appeared, and steroid therapy was effective. Altogether, EPC without typical cerebrospinal fluid features can be an early sign of anti-MOG antibody-positive encephalitis. Thus, patients with EPC of unknown etiology need to be screened for anti-MOG antibodies.

Cite

CITATION STYLE

APA

Katsuse, K., Shimizu, G., Sato, N. S., Hatano, K., Yagi, S., Kimura, T., … Hashida, H. (2020). Epilepsia partialis continua as an early sign of anti-myelin oligodendrocyte glycoprotein antibody-positive encephalitis. Internal Medicine, 59(11), 1445–1449. https://doi.org/10.2169/internalmedicine.3076-19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free